News

Hollings enrolled the first patient in a clinical trial of a new type of drug, a bifunctional antibody, for head and neck squamous cell carcinoma.

Ask researchers what the toughest part of their work is, and many will tell you it isn’t complex experiments – it's translating science into a story.

Doctor with MUSC's Aerospace and Human Performance Neurology Program talks about impact of extended time in space on astronauts' health.

Gene therapy is being used against diseases like sickle cell and hemophilia. Could it be used against cancer?

The cochlear implant team at MUSC Health adds a new clinical trial that’s testing a device that may reduce hearing loss that can happen as an implant goes in.

MUSC Health becomes first on East Coast to put under-the-skin cochlear implant in patient in national clinical trial of innovative device.

Researchers, patient advocates, health care professionals and community leaders gather to highlight latest advancements in rare disease research.

After years of decreases, cervical cancer is increasing among women who live in rural areas, research at Hollings Cancer Center shows.

Hollings researchers want to help older adults with head and neck cancer navigate treatment options that have mostly been studied among middle-aged adults.

MUSC Hollings Cancer Center researchers will test whether e-cigarettes are a viable quit smoking option for people who decline other options.